Floatz logo

Benadryl

HER-2 Negative Breast Cancer

Henan Cancer HospitalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the HER-2 Negative Breast Cancer cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
MedSIR
Phase 3BB
Cimetidine
Henan Cancer Hospital
Phase 2CCC
Utidelone
Biostar Pharma, Inc.
Phase 2CCC

Same molecule, other indications

Benadryl is also rated in:

Relapsing Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Adult Hodgkin LymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Adult Acute Myeloid LeukemiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →